Baird raised the firm’s price target on DexCom (DXCM) to $115 from $104 and keeps an Outperform rating on the shares. The firm said the second half of 2025 will see catalysts as it growth tailwinds continue to build.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: